rs755260815
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_006767.4(LZTR1):āc.2246A>Gā(p.Tyr749Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_006767.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LZTR1 | NM_006767.4 | c.2246A>G | p.Tyr749Cys | missense_variant | 19/21 | ENST00000646124.2 | NP_006758.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LZTR1 | ENST00000646124.2 | c.2246A>G | p.Tyr749Cys | missense_variant | 19/21 | NM_006767.4 | ENSP00000496779 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151776Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251216Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135852
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461374Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727018
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151776Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74098
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LZTR1 protein function. ClinVar contains an entry for this variant (Variation ID: 549754). This missense change has been observed in individual(s) with autosomal recessive Noonan syndrome (PMID: 30859559). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs755260815, gnomAD 0.003%). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 749 of the LZTR1 protein (p.Tyr749Cys). - |
Schwannomatosis 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 10, 2023 | - - |
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 21, 2021 | The p.Y749C variant (also known as c.2246A>G), located in coding exon 19 of the LZTR1 gene, results from an A to G substitution at nucleotide position 2246. The tyrosine at codon 749 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported as a variant of uncertain significance in trans with the c.1407G>A; p.W469* LZTR1 alteration in a female patient with milder noonan syndrome-like features and severe hypertrophic cardiomyopathy (Pagnamenta AT et al. Clin Genet, 2019 06;95:693-703). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Noonan syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Genomic Medicine Theme, NIHR Oxford Biomedical Research Centre, University of Oxford | Jul 02, 2018 | - - |
LZTR1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 25, 2024 | The LZTR1 c.2246A>G variant is predicted to result in the amino acid substitution p.Tyr749Cys. This variant was reported in the compound heterozygous state in an individual with Noonan syndrome with severe hypertrophic cardiomyopathy (Pagnamenta et al. 2019. PubMed ID: 30859559). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at